Inventor profile of:

Peter Rhode

City:

Miami, Florida

Country:

United States

Published Applications:

48

Last publication date:

2026-04-02

Top Assignees for applications by Peter Rhode

The entities that hold a legal rights for patent applications filed by inventor Rhode Peter:

Recent patent applications by Rhode Peter

Peter Rhode from Miami, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-02
US20260092097A1
Chemistry; metallurgy

MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

#2 | 2025-05-22
US20250161412A1
Human necessities

COMBINATION THERAPIES FOR MULTIPLE MYELOMA

#3 | 2025-05-15
US20250152686A1
Human necessities

IL-15-BASED FUSIONS TO IL-12 AND IL-18

#4 | 2025-01-16
US20250018020A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#5 | 2024-08-01
US20240252609A1
Human necessities

IL-15-BASED FUSIONS TO IL-12 AND IL-18

#6 | 2024-03-28
US20240100138A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#7 | 2024-03-07
US20240076354A1
Chemistry; metallurgy

MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

#8 | 2023-08-10
US20230248813A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#9 | 2022-12-08
US20220387570A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#10 | 2022-11-15
US16659311
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#11 | 2022-08-18
US20220257649A1
Human necessities

COMBINATION THERAPIES FOR MULTIPLE MYELOMA

#12 | 2022-03-31
US20220098268A1
Chemistry; metallurgy

HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC T CELL RECEPTORS

#13 | 2022-03-03
US20220062399A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#14 | 2022-01-06
US20220002383A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#15 | 2021-07-01
US20210196821A1
Human necessities

Multimeric IL-15-based molecules

#16 | 2021-02-04
US20210030844A1
Human necessities

IL-15-based molecules and methods of use thereof

#17 | 2021-01-14
US20210008167A1
Human necessities

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF

#18 | 2020-09-10
US20200283498A1
Chemistry; metallurgy

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF

#19 | 2020-08-20
US20200261575A1
Human necessities

Multimeric IL-15-based molecules

#20 | 2020-06-18
US20200190164A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#21 | 2020-06-11
US20200181237A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#22 | 2020-06-04
US20200172594A1
Chemistry; metallurgy

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF

#23 | 2020-05-07
US20200140513A1
Chemistry; metallurgy

Interleukin 15 (IL-15) variants

#24 | 2020-01-16
US20200016239A1
Human necessities

IL-15-based molecules and methods of use thereof

#25 | 2019-10-31
US20190330309A1
Chemistry; metallurgy

Superkine

#26 | 2019-10-31
US20190328838A1
Human necessities

COMPOSITIONS COMPRISING IL-2 FUSION PROTEINS AND METHODS FOR TREATING NEOPLASIA

#27 | 2019-02-14
US20190048055A1
Chemistry; metallurgy

ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES

#28 | 2019-02-14
US20190046623A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#29 | 2019-01-24
US20190023766A1
Chemistry; metallurgy

Method of treating neoplasia with a multimeric IL-15 soluble fusion molecule

#30 | 2019-01-24
US20190022187A1
Human necessities

IL-15-based molecules and methods of use thereof

#31 | 2018-07-19
US20180200366A1
Human necessities

MULTIMERIC IL-15-BASED MOLECULES

#32 | 2017-11-30
US20170342119A1
Chemistry; metallurgy

Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains

#33 | 2016-12-22
US20160367635A1
Human necessities

IL-15 variants and uses thereof

#34 | 2016-12-08
US20160355567A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#35 | 2016-07-28
US20160213750A1
Human necessities

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#36 | 2015-12-31
US20150374790A1
Human necessities

IL-15-based molecules and methods of use thereof

#37 | 2015-08-06
US20150216937A1
Human necessities

METHODS FOR TREATING NEOPLASIA

#38 | 2015-05-14
US20150132257A1
Chemistry; metallurgy

Methods of treating disease with fusion molecules comprising IL-15 variants

#39 | 2015-03-19
US20150079025A1
Chemistry; metallurgy

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOF

#40 | 2014-08-28
US20140242025A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of treating neoplasia and HIV using same

#41 | 2014-08-07
US20140219955A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#42 | 2014-07-24
US20140205560A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#43 | 2014-05-15
US20140134128A1
Human necessities

Multimeric IL-15 soluble fusion molecules and methods of using same

#44 | 2012-09-13
US20120230946A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#45 | 2012-07-12
US20120177595A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#46 | 2011-03-24
US20110070191A1
Chemistry; metallurgy

T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THERE OF

#47 | 2010-11-04
US20100278774A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#48 | 2009-12-31
US20090324538A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

InventorID:

761826 ⎘